Erectile Dysfunction as a Predictor of the Metabolic Syndrome in Aging Men: Results From the Massachusetts Male Aging Study

Journal of Urology

Volumn 176, Issue 1, 2006, Pages 222-226

  Kupelian, Varant ^a   Shabsigh, Ridwan ^b   Araujo, Andre B ^a   O'Donnell, Amy B ^a   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

aging; epidemiology; impotence; metabolic syndrome X

Indexed keywords

ADOLESCENT; ADULT; AGING; ARTICLE; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ERECTILE DYSFUNCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POISSON DISTRIBUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; HUMANS; IMPOTENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; WAIST-HIP RATIO;

EID: 33744535721     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(06)00503-9     Document Type: Article

References (20)

1. Heart Disease and Stroke Statistics-2005 Update (2005), American Heart Association, Dallas, Texas
2. Harris M.I., Klein R., Welborn T.A., and Knuiman M.W. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15 (1992) 815
3. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia. the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416
4. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults. findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356
5. Lorenzo C., Okoloise M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes. the San Antonio heart study. Diabetes Care 26 (2003) 3153
6. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414
7. Feldman H.A., Johannes C.B., Derby C.A., Kleinman K.P., Mohr B.A., Araujo A.B., et al. Erectile dysfunction and coronary risk factors. prospective results from the Massachusetts male aging study. Prev Med 30 (2000) 328
8. Giuliano F.A., Leriche A., Jaudinot E.O., and de Gendre A.S. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 64 (2004) 1196
9. Wei M., Macera C.A., Davis D.R., Hornung C.A., Nankin H.R., and Blair S.N. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 140 (1994) 930
10. O'Donnell A.B., Araujo A.B., and McKinlay J.B. The health of normally aging men. The Massachusetts Male Aging Study (1987-2004). Exp Gerontol 39 (2004) 975
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486
12. O'Donnell A.B., Araujo A.B., Goldstein I., and McKinlay J.B. The validity of a single-question self-report of erectile dysfunction. J Gen Intern Med 20 (2005) 515
13. Kleinman K.P., Feldman H.A., Johannes C.B., Derby C.A., and McKinlay J.B. A new surrogate variable for erectile dysfunction status in the Massachusetts male aging study. J Clin Epidemiol 53 (2000) 71
14. Bansal T.C., Guay A.T., Jacobson J., Woods B.O., and Nesto R.W. Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med 2 (2005) 96
15. Matfin G., Jawa A., and Fonseca V.A. Erectile dysfunction. interrelationship with the metabolic syndrome. Curr Diab Rep 5 (2005) 64
16. Jeremy J.Y., Angelini G.D., Khan M., Mikhailidis D.P., Morgan R.J., Thompson C.S., et al. Platelets, oxidant stress and erectile dysfunction. an hypothesis. Cardiovasc Res 46 (2000) 50
17. Kirby M., Jackson G., Betteridge J., and Friedli K. Is erectile dysfunction a marker for cardiovascular disease?. Int J Clin Pract 55 (2001) 614
18. Billups K.L., Kaiser D.R., Kelly A.S., Wetterling R.A., Tsai M.Y., Hanson N., et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res 15 (2003) 231
19. Kaiser D.R., Billups K., Mason C., Wetterling R., Lundberg J.L., and Bank A.J. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43 (2004) 179
20. Matthews J.N., and Altman D.G. Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ 313 (1996) 808